144 related articles for article (PubMed ID: 8687193)
21. Effect of plasma lipids, hypertension and APOE genotype on cognitive decline.
Yasuno F; Tanimukai S; Sasaki M; Ikejima C; Yamashita F; Kodama C; Hidaka S; Mizukami K; Asada T
Neurobiol Aging; 2012 Nov; 33(11):2633-40. PubMed ID: 22285757
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
Petersen RC; Smith GE; Ivnik RJ; Tangalos EG; Schaid DJ; Thibodeau SN; Kokmen E; Waring SC; Kurland LT
JAMA; 1995 Apr; 273(16):1274-8. PubMed ID: 7646655
[TBL] [Abstract][Full Text] [Related]
23. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.
Fleisher A; Grundman M; Jack CR; Petersen RC; Taylor C; Kim HT; Schiller DH; Bagwell V; Sencakova D; Weiner MF; DeCarli C; DeKosky ST; van Dyck CH; Thal LJ;
Arch Neurol; 2005 Jun; 62(6):953-7. PubMed ID: 15956166
[TBL] [Abstract][Full Text] [Related]
24. [Genotyping of apolipoprotein E (alleles epsilon 2, epsilon 3 and epsilon 4) from capillary blood].
Lagarde JP; Benlian P; Zekraoui L; Raisonnier A
Ann Biol Clin (Paris); 1995; 53(1-2):15-20. PubMed ID: 7574085
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
[TBL] [Abstract][Full Text] [Related]
27. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
[TBL] [Abstract][Full Text] [Related]
28. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
[TBL] [Abstract][Full Text] [Related]
30. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES
Dementia; 1996; 7(3):169-74. PubMed ID: 8740632
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of APOE genotyping in incipient Alzheimer's disease.
Petersen RC; Waring SC; Smith GE; Tangalos EG; Thibodeau SN
Ann N Y Acad Sci; 1996 Dec; 802():58-69. PubMed ID: 8993485
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample.
Harwood DG; Barker WW; Ownby RL; Mullan M; Duara R
Alzheimer Dis Assoc Disord; 2002; 16(1):8-14. PubMed ID: 11882744
[TBL] [Abstract][Full Text] [Related]
34. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.
Hu P; Bretsky P; Crimmins EM; Guralnik JM; Reuben DB; Seeman TE
J Gerontol A Biol Sci Med Sci; 2006 Jun; 61(6):616-20. PubMed ID: 16799145
[TBL] [Abstract][Full Text] [Related]
35. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study.
Katsuya T; Baba S; Ishikawa K; Mannami T; Fu Y; Inamoto N; Asai T; Fukuda M; Higaki J; Ogata J; Ogihara T
J Hypertens; 2002 Oct; 20(10):2017-21. PubMed ID: 12359980
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study.
Slooter AJ; van Duijn CM; Bots ML; Ott A; Breteler MB; De Voecht J; Wehnert A; de Knijff P; Havekes LM; Grobbee DE; Van Broeckhoven C; Hofman A
J Neural Transm Suppl; 1998; 53():17-29. PubMed ID: 9700643
[TBL] [Abstract][Full Text] [Related]
37. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.
Bondi MW; Salmon DP; Monsch AU; Galasko D; Butters N; Klauber MR; Thal LJ; Saitoh T
Neurology; 1995 Dec; 45(12):2203-6. PubMed ID: 8848194
[TBL] [Abstract][Full Text] [Related]
38. APOE-Genotype and Insulin Modulate Estimated Effect of Dietary Macronutrients on Cognitive Performance: Panel Analyses in Nondiabetic Older Adults at Risk of Dementia.
Norgren J; Sindi S; Matton A; Kivipelto M; Kåreholt I
J Nutr; 2023 Dec; 153(12):3506-3520. PubMed ID: 37778510
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.
Yaffe K; Cauley J; Sands L; Browner W
Arch Neurol; 1997 Sep; 54(9):1110-4. PubMed ID: 9311354
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E epsilon 2 allele and risk of stroke in the older population.
Ferrucci L; Guralnik JM; Pahor M; Harris T; Corti MC; Hyman BT; Wallace RB; Havlik RJ
Stroke; 1997 Dec; 28(12):2410-6. PubMed ID: 9412623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
